Our Company
ISTA Pharmaceuticals is an ophthalmic pharmaceutical company. The Company’s products addressing the $3.2 billion U.S. prescription ophthalmic industry include therapies for inflammation, ocular pain, glaucoma, allergy, dry eye, and vitreous hemorrhage. ISTA currently markets three products: XibromTM (bromfenac sodium ophthalmic solution) for the treatment of inflammation and pain following cataract surgery, Istalol® (timolol maleate ophthalmic solution) for the treatment of glaucoma, and Vitrase® (hyaluronidase for injection) for use as a spreading agent.
The Company also is developing a strong product pipeline to fuel future growth and market share. ISTA’s product development and commercialization strategy is to launch a new product every 12 to 18 months, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S.
Our Product Pipeline
Company Information
We are organized as a Delaware corporation. Our principal executive offices are located at 15295 Alton Parkway, Irvine, CA 92618, and our telephone number is (949) 788-6000. |
